Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel

BACKGROUND: Morbidity due to schistosomiasis is currently controlled by treatment of schistosome infected people with the antihelminthic drug praziquantel (PZQ). Children aged up to 5 years are currently excluded from schistosome control programmes largely due to the lack of PZQ safety data in this...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mutapi, Francisca, Rujeni, Nadine, Bourke, Claire, Mitchell, Kate, Appleby, Laura, Nausch, Norman, Midzi, Nicholas, Mduluza, Takafira
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2011
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3096601/
https://ncbi.nlm.nih.gov/pubmed/21610855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0001143
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים